Blog

Notes from inside the build.

What I am seeing in pharma, AI, and the work of building things people actually use.

A precise analog clock face rendered in soft grey on a deep navy background, with one teal hand near the start of the dial and a faded ghost hand near the far end, suggesting compression of time

Featured· AI

Your Pharma Is Losing 21 Days on Every Cross-Functional Decision. Here Is How to Stop It.

Every cross-functional decision inside your pharma is routing through five to twelve stakeholders, and the math on that cascade adds twenty-one days to your timeline before anyone has actually disagreed

June 8, 2026 · 4 min read

AllAIBusinessPharma
Six small grey gear icons on a deep navy background, arranged in a clean horizontal row, with each gear progressively highlighted in teal from left to right

Pharma, AI

The 6 Pharma Field Force Workflows That Should Already Be Automated in 2026

Pharma reps spend 72% of the week not selling. McKinsey says 75-85% of workflows can now be automated. Here are the 6 field force workflows ready to ship in 2026.

Jun 16 · 3 min read

A row of grey product silhouettes on a soft navy background, with a single teal arrow curving away from the row toward a teal user icon, suggesting a direct brand-to-consumer connection bypassing the retail shelf

Business, Pharma, AI

Channel-Agnostic Loyalty: Why the Retail Pharmacy Owns Your Customer, Not You

Your brand sells through retail. The retailer owns the customer data. Private label is at record share. Here is the channel-agnostic loyalty platform that closes the gap.

Jun 14 · 3 min read

A single sheet of marketing copy on a soft grey background, with a thin teal line running diagonally across its lower half as if redacting a portion of the text

Pharma, AI

Why Generative AI in Pharma Marketing Will Trigger the Next FDA Wave

In 2025, the FDA issued over two hundred enforcement letters challenging prescription drug advertising, the highest annual total in nearly twenty-five years

May 29 · 3 min read

Two stacked rectangular blocks on a soft grey background, the lower block roughly twice the size of the upper, with a faint teal accent line running between them

Pharma, AI

Why Mid-Size Pharma Will Lose the AI Race

Eli Lilly is building a one-billion-dollar AI supercomputer with Nvidia. Johnson & Johnson, Roche, Pfizer, and Novo Nordisk have direct partnerships with the four largest AI infrastructure providers in the world.

May 28 · 3 min read

A single empty hotel banquet chair photographed from an angle on a soft grey background, with a faint teal pattern of light on the floor beside it

Pharma, Business

Speaker Programs Are Quietly Dying

Speaker programs have been the backbone of pharma HCP engagement for thirty years. They are now collapsing under three converging pressures at once.

May 27 · 3 min read

A precise stopwatch face rendered in soft grey on a deep navy background, with a single teal indicator line at the eighteen-month mark

Pharma, AI

AI in Pharmacovigilance: The 18-Month Window

Pharmacovigilance is the function where the volume math has already broken. Manual processing cannot scale. AI is forced, not optional.

May 26 · 3 min read

An empty boardroom table photographed from above on a soft grey background, with a single sheet of paper at the head of the table marked with a faint teal accent

Pharma, AI, Business

Pharma Boards Are Approving AI They Don't Understand

Pharma boards are signing off on billion-dollar AI commitments while two-thirds of directors admit they have limited or no AI knowledge.

May 25 · 3 min read

A single white regulatory document standing upright on a deep grey background, rendered in soft editorial light with a faint teal accent line cutting diagonally across the page

Pharma, Business, AI

What the EU AI Act Means for Pharma

Most of the AI a pharma company is currently building lands in the high-risk tier of the EU AI Act by default.

May 24 · 3 min read

A large dollar figure rendered in soft black on a pure white background, with a thin teal line beneath it

Pharma, AI

The Real Cost of a Failed Pharma AI Pilot

The average sunk cost of an abandoned enterprise AI project is 7.2 million dollars. The pharma-specific picture is worse. 95 percent of pharma AI pilots fail to reach production.

May 23 · 3 min read

A steep downward sloping line graph rendered in soft black on a pure white background, with the slope highlighted in teal

Pharma, Business

The 2030 Patent Cliff: $400 Billion in Branded Pharma Revenue at Risk

Between 2025 and 2030, somewhere between 200 and 400 billion dollars in branded pharmaceutical revenue will lose patent protection. Keytruda, Stelara, Eliquis, Eylea, Ozempic by 2032.

May 22 · 3 min read

A single large numeral one followed by twelve zeros rendered in soft black on a pure white background, with a teal underline

Pharma, Business

Lilly Hit $1 Trillion. What That Means for the Next Decade of Pharma

On November 21, 2025, Eli Lilly became the first pharmaceutical company in history to cross a one trillion dollar market capitalization. The lesson is what pharma boards must internalize about the next decade of value

May 21 · 3 min read

A solitary pharmacy counter rendered in soft grey on a white background, with a single teal figure standing behind it surrounded by negative space

Pharma, Business

The Pharmacist Pharma Forgot

Community pharmacists are the most accessed healthcare professional in most markets, the most trusted on medication decisions, and the most under-engaged stakeholder in pharma's commercial strategy.

May 19 · 3 min read

A document with a teal underline tracking through it, showing structure and accountability

Pharma, AI

The Audit Trail Problem: Why Pharma's AI Deployments Will Face FDA Scrutiny by 2027

The FDA issued 40 untitled letters in a single day in September 2025. The next enforcement wave will target AI-driven decisions without audit trails. Here is why your pharma company needs to act now.

May 11 · 3 min read

A bright spark icon in grey alongside a solid foundation block in teal, signaling boring beats flashy

AI, Pharma

Why Pharma's Best AI Bets Are Boring (And Why That's the Point)

The AI investments that will define pharma's next decade are not the flashy ones. They are the boring ones. Here is what to look for and why your CFO will not approve them.

May 10 · 3 min read

Pie chart abstraction with 70% in grey and 30% in teal, broken further into a smaller half in lighter teal

Pharma, Business

The MSL Productivity Paradox: 70% Admin, 30% Science

Medical Science Liaisons spend 70% of their time on admin. Of the 30% they spend on science, half is rework. Here is the data and the structural cause.

May 7 · 3 min read

Abstract layered briefing document on white, with one transparent layer highlighted in teal

AI, Business, Pharma

How to Brief an AI Agent Like a Senior Partner: A Pharma Operator's Framework

Most pharma teams brief AI agents like search engines. The teams getting results brief them like senior associates. Here is the framework that changes the output.

May 6 · 3 min read

Two abstract human figures rendered in grey on a white background, with a single figure highlighted in teal among a much smaller cluster

Pharma, Business

The Field Force Reckoning: Why Pharma Is Cutting 50% of Its Reps by 2028

Pfizer cut 7,500 reps in 2024. Bayer announced 1,500 in early 2026. Sanofi cut 800 in March. The era of the 600-rep field force is ending. Here is what is replacing it.

May 5 · 3 min read

Abstract handoff motif on white, a geometric shape passing from a grey hand silhouette into a network of teal lines

Pharma, AI

Why I Built Human in the Loop for Pharma

Pharma leaders make hundreds of decisions a week with no audit trail. Human in the Loop is the AI deployment model that makes pharma accountable.

Apr 29 · 3 min read

Abstract funnel on white background with patient dots flowing through, most falling away in grey, one continuing in teal

Pharma, Business

The Patient Your Pharma Forecast Forgot

Pharma forecasts are built in three stages by three different teams. The third arrives too late to change anything. Here is why and what to fix.

Apr 15 · 3 min read

Abstract architectural foundation rendered in grey grid blocks supporting a smaller component highlighted in teal

Pharma, AI

AI in Pharma Is an Architecture Decision, Not a Procurement One

Most pharma boardrooms ask which AI model to buy. The companies winning are asking which architecture to build. Here is why that matters.

Apr 8 · 3 min read

all of grey rectangles representing ignored pharma emails with a single rectangle highlighted in teal

Pharma, AI

Pharma Spends $6.2B on HCP Marketing. 97% Gets Ignored.

Pharma spent 6.2 billion dollars on HCP digital marketing in 2025. 97 percent of it got ignored. Here is the data and what actually works.

Apr 1 · 3 min read

Two abstract upward trajectory lines diverging on a white background, one continuing to rise in teal and one declining in grey

Pharma, Business

Why 66% of Drug Launches Miss Their Forecast in 2026

Two thirds of pharma drug launches miss first year sales targets. The real reason is not the molecule. It is the commercial system around it.

Mar 25 · 3 min read

Get new posts in your inbox.

No spam. No funnel sequences. Just new writing when it ships.

Unsubscribe anytime. Your email is never sold.